Rikkunshito (traditional medicine) combined with serotonin 5-HT2C receptor antagonism improved cisplatin-induced appetite loss through hypothalamic ghrelin pathway enhancement — integrating traditional and pharmacological approaches.
Key findingRikkunshito (traditional medicine) combined with serotonin 5-HT2C receptor antagonism improved cisplatin-induced appetite loss through hypothalamic gh
What the researchers found
Rikkunshito (traditional medicine) combined with serotonin 5-HT2C receptor antagonism improved cisplatin-induced appetite loss through hypothalamic ghrelin pathway enhancement — integrating traditional and pharmacological approaches.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
Regulatory peptides, 161(1-3), 97-105
Citation
Yakabi, Koji; Kurosawa, Susumu; Tamai, Mitsuo; Yuzurihara, Mitsutoshi; Nahata, Miwa; Ohno, Shino; Ro, Shoki; Kato, Shingo; Aoyama, Toru; Sakurada, Tomoya; Takabayashi, Hidehiko; Hattori, Tomohisa. (2010). Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.. Regulatory peptides, 161(1-3), 97-105. https://doi.org/10.1016/j.regpep.2010.02.003